Funding Opportunities Related To COVID-19

Last updated on January 25, 2021

The OSR, Office of Clinical Trial Activation (OCTA), and Contracts and Grants Accounting (CGA) are working to ensure continuity of services for researchers, as well as prioritizing COVID-19 research and clinical trials.

Go to our COVID-19 page for sponsor specific guidance, the impact of research and additional resources

Please visit the Office of Research COVID-Related Research website to find a searchable list of all COVID related funding opportunities

 

Please notify your RSC of any intention to submit a proposal ASAP.

Below is a list of NIH funding opportunities only.  The charts below are separated by:

These funding opportunities are also part of the searchable list on the Office of Research COVID website

NIH - National Institutes of Health

Go to the NIH COVID-19 Information for NIH Applicants and Recipients page for a complete list of Funding Opportunities Specific to COVID-19

OD - NOT-OD-20-162 Request for Information (RFI): Inviting Comments and Suggestions on University-Based Approaches for COVID-19 Surveillance Testing to Review the Current Landscape Response Due Date: August 26, 2020

OD - NOT-OD-20-118 Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency

Related NOSIs: NOT-AT-20-011, NOT-MD-20-019, NOT-AG-20-022, NOT-ES-20-020, NOT-AA-20-011, NOT-HG-20-030, NOT-GM-20-025, NOT-MH-20-047,NOT-OD-20-097, NOT-DA-20-047, NOT-LM-20-010, NOT-OD-20-107 

 

NCI - NOT-CA-20-082 NOSI: NCI Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19) Rolling Submission from July 2, 2920 through August 14, 2020

 

NCI - NOT-CA-20-065 Request For Information (RFI): Strategy for Research in Coronavirus Serology Testing and Serological Sciences, Response Due: May 26, 2020

 

NCI - NOT-CA-20-054 Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be redirected to COVID-19-Related Research During the Crisis

 

NHLBI - Research Opportunity Announcement (ROA) OTA-20-011 ACTIV Integration of Host-targeting Therapies for COVID19 Stage 1 Letters of Request Due: Friday, May 15, 5 PM EDT. Additional letters of request considered on a monthly basis June 15, July 15, and August 15.

 

NIBIBNIH POCTRN - Fast-Track Program for COVID-19 Test Development and Distribution Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing Rolling Submission from April 29, 2020 until further ntoice.

 

COVID-19 Applications:

NIH IC NOSI NOSI Expiration Title FOAs Used

NIAID/NIEHS

     
  • RFA-AI-20-078 Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed) AIDS and non-AIDS Application Due Date: June 4, 2021

NIAID/NIEHS

     
  • RFA-AI-20-077 Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed) AIDS and non-AIDS Application Due Date: June 4, 2021

NIDA/NIAAA

NIBIB/NIEHS

NIMH/NINDS

NIMHD/OBSSR/ORWH

     
  • RFA-DA-21-023 HEAL Initiative: HEALthy Brain and Child Development Data Coordinating Center (U24) Application Reciept Date: March 31, 2021

NIDA/NIAAA

NIBIB/NIEHS

NIMH/NINDS

NIMHD/OBSSR/ORWH

     
  • RFA-DA-21-022 HEAL Initiative: HEALthy Brain and Child Development Consortium Administrative Core (U24 - Clinical Trial Not Allowed) Application Reciept Date: March 31, 2021

NIDA/NIAAA

NIBIB/NIEHS

NIMH/NINDS

NIMHD/OBSSR/ORWH

     
  • RFA-DA-21-021 HEAL Initiative: HEALthy Brain and Child Development Study (U01 - Clinical Trial Not Allowed) Application Reciept Date: March 31, 2021

NIDA/NIAAA

NIBIB/NIEHS

NIMH/NINDS

NIMHD/OBSSR/ORWH

     
  • RFA-DA-21-020 HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed) Application Reciept Date: March 31, 2021

FDA/CDER

     
  • RFA-FD-21-012 Physiologically Based Pharmacokinetic (PBPK) Models of Oral Absorption to Simulate the Results of Bioequivalence Studies (U01) Clinical Trials Optional Application Reciept Date: March 15, 2021. Early applications are encouraged.

NCATS

     
  • PAR-21-121 Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional) Application Receipt Dates: March 26, 2021; June 17, 2021; October 19, 2021; February 17, 2022; June 17, 2022; October 18, 2022; February 17, 2023; June 19, 2023; October 17; 2023

NIMH

NOT-MH-21-120 06/02/23 Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research
  • PA-20-272 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) Applications accepted on or after January 5, 2021 with rolling receipt through June 1, 2023

     

NCATS

NOT-TR-21-011 06/02/21 Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs
  • PA-20-272 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) Applications will be accepted immediately and on a rolling basis through June 1, 2021

NIMHD/NHLBI

NIAID/NIAMS

NIDCR/NIMH

NINR/NCI 

 NOT-MD-21-008  01/08/22 Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities

NIAID

NOT-AI-21-002 6/12/21 Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects
  • PAR-20-072 NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) Application Receipt Dates: January 11, 2021 and June 11, 2021
  •  

 

NOT-DA-20-084 9/8/24 Effects of Smoking and Vaping on the Risk and Outcome of COVID-19
  • PA-20-183 NIH Research Project Grant (Parent R01 Clinical Trial Required) Due Dates on or after January 7, 2021 and subsequent receipt dates through September 7, 2024

  • PA-20-200 NIH Small Research Grant Program (Parent R03 Clinical Trail Not Allowed) Due Dates on or after January 7, 2021 and subsequent receipt dates through September 7, 2024
  • PA-20-195 NIH Exploratory/Developmental Research Grant (Parent R21 Clinical Trial Not Allowed) Due Dates on or after January 7, 2021 and subsequent receipt dates through September 7, 2024

NCATS

NOT-TR-21-006 3/17/21 Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)
  • PAR-17-465 Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3) Application Receipt Dates on or after October 30, 2020 and subsequent receipt dates through March 16, 2021

  • PAR-18-462 Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34 Clinical Trial Not Allowed) Application Receipt Dates on or after October 30, 2020 and subsequent receipt dates through March 16, 2021

  • PAR-18-332 Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical Trial Required) Application Receipt Dates on or after October 30, 2020 and subsequent receipt dates through March 16, 2021

NIDCR

     
  • PAR-2O-306 National Dental Practice-Based Research Network Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical trial Optional) Non-AIDS Due Dates: November 19, 2020, February 9, 2021, June 9, 2021, and October 8 2021; February 9, 2022, June 9, 2022, and October 7 2022; February 9 2023, June 9, 2023                                                           AIDS Due Dates: January 7, 2021, May 7, 2021, and September 7 2021; January 7, 2022, May 7, 2022, September 7 2022; January 7, 2023, May 7, 2023, September 7 2023

NIMHD/

NIAAA/

NIDA/ODP/

OBSSR/

ORWH

     
  • PAR-20-310 Health Services Research on Minority Health and Health Disparities (R01 Clinical Trial Optional) Non-AIDS Due Dates: November 27, 2020, March 17, 2021, November 17, 2021, March 17, 20o22, November 17, 2022, February 17, 2023                                            AIDS Due Dates: November 27, 2021; March 17, 2021; November 17, 2021; March 17, 2022; November 17, 2022; March 17, 2023.

NICHD

NOT-HD-20-031 05/08/23 Research on Rehabilitation Needs Associated with the COVID-19 Pandemic
  • PA-20-185 NIH Reseearch Project Grant (Parent R01 Clinical Trial Not Allowed) Due Dates on or after February 5, 2021 and subsequent receipt dates through May 8, 2023

  • PA-18-480 NICHD Research Project Grant (Parent R01 Clinical Trial Required) Due Dates on or after February 5, 2021 and subsequent receipt dates through May 8, 2023

  • PA-20-200 NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) Due Dates on or after February 5, 2021 and subsequent receipt dates through May 8, 2023
  • PA-20-194 NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) Due Dates on or after February 5, 2021 and subsequent receipt dates through May 8, 2023

CDC/NIOSH

     
  • PAR-20-312 State Occupational Safety and Health Surveillance Program (U60)

  •  Letter of Intent Due Dates: October 30, 2020, August 10, 2021, August 10, 2022  

  • Application Due Dates: December 16, 2020, September 14, 2021, September 14, 2022

NHLBI

NOT-HL-20-814 07/06/24 The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)
  • PA-20-183 Research Project Grant (Parent R01 Clinical Trial Required) Due Dates on or after October 5, 2020 and subsequent receipt dates through July 5, 2024 or reissued FOAs

  • PA-20-185 Research Project Grant (Parent R01 Clinical Trial Not Allowed) Due Dates on or after October 5, 2020 and subsequent receipt dates through July 5, 2024 or reissued FOAs

NIDDK

     
  • RFA-DK-20-506 Limited Competition for the Continuation of the Urinary Stone Disease Research Network (USDRN) Clinical Center (U01 Clinical Trial Required) Due Date: February 9, 2021

  • RFA-DK-20-507 Limited Competition for the Continuation of the Urinary Stone Disease Research Network (USDRN) Scientific Data Research Center (U24 Clinical Trial Required) Due Date: February 9, 2021

NICHD/NIAID

     
  • PAR-20-298 Development of the Fetal Immune System (R01 Clinical Trial Not Allowed) AIDS and Non-AIDS Application Due Dates: April 7, 2021, December 7, 2021, April 7, 2022, December 7, 2022, April 7, 2023, December 7, 2023

     

NINDS/NEI/

NHLBI/NIA/

NIAAA/NICHD/

NIDCD/NIDA/

NIGMS/NIMH/

NIMHD/NCI

NOT-NS-20-005 12/08/22

NOSI: Research in the Emergency Setting

  • Applicants must select the IC and associated FOA to use for submission of an application in response to this NOSI.  Please see NOSI for IC Specific Application and Submission Information.

     

NCI/ODP

     
  • PAR-20-302 Tomaco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) Due Dates: November 12, 2020, thereafter Standard dates apply

  • PAR-20-303 Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional) Due Dates: November 12, 2020, thereafter Standard dates apply

NICHD/ORWH

NOT-HD-20-021 07/16/23 Emerging Viral Infections and Their Impact on the Male and Female Reporductive Tract
  • PA-20-185 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) Due Dates: on or after October 5, 2020 and subsequent receipt dates through July 16. 2023

  • PA-18-482 NICHD Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) Due Dates: on or after October 5, 2020 and subsequent receipt dates through July 16, 2023

NICHD

     
  • RFA-HD-21-023 NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional) Due Date: only accepting applications for the March 31, 2021 AIDS due date

NIAID

NOT-AI-20-065 09/01/21 Availability of Emergency Awards for limited Clinical Trials to Evaluate Therapeutic and vaccine Candidates Against SARS-CoV-2
  • PAR-18-633 NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) Due Dates: once per month from September 14, 2020 through September 14, 2021

NIMHD

NOT-MD-20-026 05/08/21 Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Health Disparity Populations
  • PA-20-183 NIH Research Project Grant (Parent R01 Clinical Trial Required) Due Dates: on or after October 5, 2020 and subsequent receipt dates through May 8, 2021

  • PA-20-185 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) Due Dates: on or after October 5, 2020 and subsequent receipt dates through May 8, 2021

NIMHD/NIAMS/

NIDA/NIMH/

NLM/NCI/ODP/

OBSSR

NOT-MD-20-025

NOT-MD-20-030 corrects submission information

05/08/23 Simulation Modeling and Systems Science to Address Health Disparities
  • PA-20-185 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) Due Dates: on or after October 5, 2020 and subsequent receipt dates through May 8, 2023

NIA      
  • PAR-20-234 NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) Due Dates: July 1, 2020, August 3, 2020, September 1, 2020, October 1, 2020, November 2,2020, December 1, 2020, January 4, 2021, and February 1, 2021 
NIAID      
  • PA-20-195 NIH Exploratory Developmental Research Grant Program (Parent R21 Clinical Trail Not Allowed)
  • PA-19-056 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
NIAID

NOT-AI-20-051

Early Termination

NOT-AI-20-066

9/8/21

9/8/20

Select Research Areas for Severe Acute-Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
  • PA-20-200 NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) Standard Due Dates apply, first Standard Due Date is June 16, 2020. Standard AIDS Dates apply, first Standard AIDS Date is September 7, 2020 
OPPNET, NIA, NIAAA, NICHD, NIDA, NIMH, NINDS, NINR, NIMHD, NCCIH, OBSSR NOT-OD-20-103 3/18/21 Notice of Additional Due Date and Additional "Areas of Focus Especially of Interest" of PAR-19-373 and PAR-19-384
  • PAR-19-373 Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01-Clinical Trials Not Allowed) Due: 6/8/20, 3/17/21
  • PAR-19-384 Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01-Basic Experimental Studies with Humans Required) Due: 6/8/20, 3/17/21
NIDA

NOT-DA-20-058

1/8/24

Utilizing Telemedicine or Other Remote-Based Platforms to Develop and Support Treatments for Substance Use Disorders

  • PA-20-185 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) DUE: Standard Due Dates on or after October 5,2020 through January 8, 2024
  • PA-20-183 Research Project Grant (Parent R01 Clinical Trial Required) DUE: Standard Due Dates on or after October 5,2020 through January 8, 2024
  • PA-20-195 NIH Exploratory Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) DUE: Standard Due Dates on or after October 5,2020 through January 8, 2024
  • PA-20-194 NIH Exploratory Developmental Research Grant Program (Parent R21 Clinical Trial Required) DUE: Standard Due Dates on or after October 5,2020 through January 8, 2024
NIDCD

NOT-DC-20-008

9/8/20

NIDCDE is Interested in Supporting Research on the Impact of COVID-19 on Mission specific Sensory and Communication Disorders

This NOSI applies to due dates on or after October 5, 2020 and subsequent receipt dates through September 8, 2022

  • PA-18-334 NIDCD Clinical Trials in Communication Disorders (R01 Clinical Trial  Required) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-20-185 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-20-184 NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-20-196 NIH Exploratory Development Research grant Program (Parent R21 Basic Experimental Studies with Humans Required) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-20-195 NIH Exploratory Developmental Research Grant Program (R21 Clinical Trial Not Allowed) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-20-194 NIH Exploratory Developmental Research Grant Program (Parent R21 Clinical Trial Required) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-19-270 PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR R41/R42 Clinical Trial Not Allowed) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-19-271 PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR R41/R42 Clinical Trial Required) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-19-273 PHS 2019-02 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR R43/R44 Clinical Trial Required) Standard Due Dates on or after 10/5/20 throuth 9/8/22
  • PA-19-272 PHS 2019-02 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR R43/R44 Clinical Trial Not Allowed) Standard Due Dates on or after 10/5/20 throuth 9/8/22
NIDCR

NOT-DE-20-023

FAQs

  Infrastructure Access for Research on Coronavirus disease 2019 (COVID-19) Conducted in the National Dental Practice-based Research Network
  • PAR-20-073 National Dental Practice-based Research Network Infrastructure Access (X01 Clinical Trial Not Allowed) Due: 6/1/20, 9/1/20, 11/2/20, 9/1/21, 9/1/22
NCATS NOT-TR-20-012 10/17/20 Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)
  • PA-18-462 Clinical Trial Planning Therapeutic/Indication Pairing Strategies (U34 Clinical Trial Not Allowed) Standard Dates Apply
  • PAR-18-332 Clinic Testing Therapeutic/Indications Pairing Strategies (U01 Clinical Trial Required) Standard Dates Apply
NIEHS

NOT-ES-20-015

 Rescinded 4/10/20

replaced by NOT-ES-20-20

4/9/20 NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
  • RFA-ES-19-011 Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) Due: see RFA

 

  TOP

COVID-19 Supplements for Exisiting Awards:

NIH IC

COVID NOSI

Competitive

PA-20-
135
expands scope

Competitive 

PA-18-
935

expands scope

Adminis. 

 PA-18-
591

within scope

Noted 

Requirements 

(See NOSI for requirements
specified)

Deadline Release Expires

NHGRI

NOT-HG-21-020

  X  

Request to exceed the $250K per year DC cap for particularly meritorious work must be received by January 8, 2021

Rolling basis from 12/15/20 through 1/15/21 12/10/20  1/16/21

OD/NHLBI

NHGRI/NIAID

NIAMS/NICHD

NIDCD/NIDCR

NIDDK/NIEHS

NINDS/NIMHD

NCCIH/NCATS

NCI/ORIP

NOT-OD-20-129

NOT-AG-20-055

Announces NIA withdrawal 12/1/20

  X X   7/12/20 11/12/20 3/12/21 7/12/21  6/25/20 7/13/21
NIAID

NOT-AI-20-059

X    

Specific areas of support limited to active BSL3 facilities, generation of critical reagents, expansion of relevant data systems, expansion of CT infrastructure.

See Notice for details

Rolling basis from 7/2/20 to 7/2/21 7/6/20 7/2/21
NIAID

NOT-AI-20-034

Rescinded 7/6/20

Replaced by NOT-AI-20-059

X     FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25  Rolling basis from 3/25/20-3/25/21

 3/25/20

7/6/20

 3/25/21

 

NIAID

NOT-AI-20-031

Rescinded 5/19/20

Replaced by NOSI NOT-AI-20-051 R03, R41/R42, R43/R44 

or use

PAR-177 PAR-178

See Application Grid above

    X

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25

 Rolling basis from 4/5/20-4/5/21  3/27/20

 4/5/21

5/19/20

NCATS NOT-TR-20-017 X    

Only existing UG3/UH3, R43/R44, R41/R42, R01, U01 NCATS/NIH Microphysiological Systems

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25

Rolling basis from 5/15/20-1/25/22 4/9/20 1/26/22
NIAAA

NOT-AA-20-011

See

NOT-OD-20-118

Data Sharing Expectations

  X X

Admin. Supp. Cannot use streamline submission in eRA.

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Rolling basis 5/15/20-4/16/21 4/16/20 4/16/21

NIA/

NIMH

NOT-AG-20-022

FAQs

See

NOT-OD-20-118

Data Sharing Expectations

  X X

Admin. Supp. Cannot use streamline submission in eRA.

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Rolling basis from 4/6/20-5/1/21 4/2/20 5/21/21
NIDA

NOT-DA-20-047

See

NOT-OD-20-118

Data Sharing Expectations

  x x

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/25/20

Rolling basis from 3/19/20-3/31//21 3/19/20 3/31/21
NIGMS

NOT-GM-20-025

See

NOT-OD-20-118

Data Sharing Expectations

  X    

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25

 Rolling basis from 3/25-2/5/21  3/25/20  2/6/21

NIMHD

NIA/

NIMH

NOT-MD-20-019

See

NOT-OD-20-118

Data Sharing Expectations

NOT-MD-21-001

NIMHD withdraws 10/01/20

  X X

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Rolling basis from 5/1/20-5/1/21 4/9/20 5/1/21

NIMH

NIA/

NIAAA/

NIMHD/

ODP

NOT-MH-20-047

See

NOT-OD-20-118

Data Sharing Expectations 

NOT-MD-21-005    NIMHD withdrawals 10/19/20

  X X

May be co-funded by ODP

FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25

Applications intended for NIMHD received 1019/20 or later will be withdrawan

Rolling basis from 3/27/20-4/15/21 4/9/20 4/16/21

NINDS

NOT-NS-20-051

NOT-NS-20-074 adds RF1 to eligible mechanisms

  X X

Limited to P01, P50, RF1,R00, R01, R03, R15, R33, R35, R41, R42, R43, R44, R61, U01, U19, U24, U44, U54, UG3, UH3

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25

Rolling basis from 4/15/20-4/14/21 4/30/20 4/15/21

OBSSR/

NHLBI/

NIA/

NIAAA/

NIDDK/

NIEHS/

NCCIH/

NCI

NOT-OD-20-097

See

NOT-OD-20-118

Data Sharing Expectations

  X X

Admin. Supplement cannot use streamline submission in eRA Commons

FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25

Rolling basis from 4/13/20-3/31/21 4/13/20 4/1/21

NCATS

NOT-TR-20-011     X

Supplements U01-PAR-19-099 R21-PAR-19-100 UL1-PAR-19-337

Admin. Supp. cannot use streamline submission in eRA Commons.

FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25

5/4/20 AND 11/2/20 3/24/20 7/10/21

1/12/21

 TOP

 

 Go to our COVID-19 page for sponsor specific guidancethe impact of research and additional resources